Valoración radiológica del anticonceptivo permanente de inserción histeroscópica Essure

Ramos, Rosa María Lorente; Armán, Javier Azpeitia; Rodríguez-Miñón, Pablo Aparicio; Arquero, F.J. Salazar; Merino, J.C. Albillos

doi:10.1016/j.rx.2014.12.006

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in the US, the FDA required HSG as part of the protocol prior to discontinuation of the contraceptive method in use. 25 Therefore, it is clear the need to create protocols by the services to better systematize and standardize the conducts performed, enabling the optimization of the results found in different countries.…”

Section: Discussionmentioning

confidence: 99%

Results of the Insertion of Hysteroscopic Sterilization Devices in a Brazilian Public Hospital

Pastore

Silva²,

Lasmar

2020

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

Objective To evaluate the insertion of the hysteroscopic intratubal sterilization device for female sterilization concerning the technique and the feasibility. Methods Retrospective study with data collection of medical records of 904 patients who underwent device insertion between January and September 2016 in a public hospital in Rio de Janeiro (Brazil) with data analysis and descriptive statistics. Results In 85.8% of the cases, the uterine cavity was normal, and the most commonly-described findings upon hysteroscopy were synechiae (9.5%). The procedure lasted an average of 3.56 minutes (range: 1 to 10 minutes), and the pain was considered inexistent or mild in 58,6% of the cases, mild or moderate in 32,8%, and severe or agonizing in less than 1% (0.8%) of the cases, based on a verbal scale ranging from 0 to 10. The rate of successful insertions was of 85.0%, and successful tubal placement was achieved in 99.5% of the cases. There were no severe complications related to the procedure, but transient vasovagal reactions occurred in 5 women (0.6%). Conclusion Female sterilization performed by hysteroscopy is a safe, feasible, fast, and well-tolerated procedure. The rates of successful insertions and tubal placements were high. There were few and mild adverse effects during the procedure, and there were no severe complications on the short term.

show abstract

Section: Discussionmentioning

confidence: 99%

Results of the Insertion of Hysteroscopic Sterilization Devices in a Brazilian Public Hospital

Pastore

Silva²,

Lasmar

2020

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

show abstract

Radiological assessment of the placement of Essure® in order to reduce hysterosalpingography: Pelvic X-ray versus combined pelvic X-ray and ultrasound

Petit

Vernet²,

Verpillat

et al. 2017

Journal of Gynecology Obstetrics and Human Reproduction

View full text Add to dashboard Cite

Safety and patients’ satisfaction after hysteroscopic sterilisation

Palacios

Jiménez-Caraballo

Tato-Varela

et al. 2017

Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

The aim of this study was to understand the potential complications of the Essure device as well as the factors influencing its onset and patient satisfaction. We present a 9-year descriptive prospective study that included 1068 patients. The device was placed in 1056 of them (98.8%); 894 had no pain or mild pain during the insertion and only 12 patients experienced pain greater than menstrual pain. The proportion of patients without pain was greater in the group that took NSAIDs or NSAIDs and BZD and the unmedicated group had the highest rate of severe pain (p = .00). In all, 161 of the 1064 patients who had the Essure inserted reported having an adverse effect during the 3-months post-insertion (pelvic pain or discomfort). The mean score out of 10 attributed to this method was 9.06 (S = 1.11). We concluded that the Essure shows a low rate of complications and users showed a high degree of satisfaction. Impact statement What is already known on this subject: There are few international publications on Essure. When we conducted a search in PubMed for the term 'Essure', we obtained 221 publications. When we added the terms 'Essure and complications', we obtained 20 publications, and when we increased the restriction including 'satisfaction', we obtained seven; thus, the uniqueness of our study. What the results of this study add: We present a 9-year descriptive prospective study that included 1068 patients. The aim of this study was to understand the potential complications of the Essure device (Bayer, Whippany, NJ), as well as factors that can influence its onset and the patient satisfaction. The device was placed in 1056 of the patients (98.8%); 894 had no pain or mild pain during the insertion and only 12 patients experienced pain greater than menstrual pain. The proportion of patients without pain was greater in the group that took NSAIDs or NSAIDs and BZD and the unmedicated group had the highest rate of severe pain (p=.00). What the implications are of these findings for clinical practice and/or further research: Our study shows a low rate of complications with Essure, mild and transient in most cases, as well as a high degree satisfaction. Nevertheless, given the few published studies on this device, we believe that long-term follow-up is needed.

show abstract

Valoración radiológica del anticonceptivo permanente de inserción histeroscópica Essure

Cited by 3 publications

References 18 publications

Results of the Insertion of Hysteroscopic Sterilization Devices in a Brazilian Public Hospital

Results of the Insertion of Hysteroscopic Sterilization Devices in a Brazilian Public Hospital

Radiological assessment of the placement of Essure® in order to reduce hysterosalpingography: Pelvic X-ray versus combined pelvic X-ray and ultrasound

Safety and patients’ satisfaction after hysteroscopic sterilisation

Contact Info

Product

Resources

About